Skip to main content

Frontotemporal dementia with parkinsonism-17

Frontotemporal dementia with parkinsonism-17 (FTDP-17) is a brain disorder. It is part of a group of conditions, called frontotemporal dementia or frontotemporal degeneration, that are characterised by a loss of nerve cells (neurons) in areas of the brain called the frontal and temporal lobes. Over time, a loss of these cells can affect personality, behaviour, language, and movement.

Description

Frontotemporal dementia with parkinsonism-17 (FTDP-17) is a brain disorder. It is part of a group of conditions, called frontotemporal dementia or frontotemporal degeneration, that are characterised by a loss of nerve cells (neurons) in areas of the brain called the frontal and temporal lobes. Over time, a loss of these cells can affect personality, behaviour, language, and movement.

The signs and symptoms of FTDP-17 usually become noticeable in a person's forties or fifties. Most affected people survive 5 to 10 years after the appearance of symptoms, although a few have survived for two decades or more.

Changes in personality and behaviour are often early signs of FTDP-17. These changes include a loss of inhibition, inappropriate emotional responses, restlessness, neglect of personal hygiene, and a general loss of interest in activities and events. The disease also leads to deterioration of cognitive functions (dementia), including problems with judgement, planning, and concentration. Some people with FTDP-17 develop psychiatric symptoms, including obsessive-compulsive behaviors, strongly held false beliefs (delusions), and false perceptions (hallucinations). It may become difficult for affected individuals to interact with others in a socially appropriate manner. They increasingly require help with personal care and other activities of daily living.

Many people with FTDP-17 develop problems with speech and language. They may have trouble finding words, confuse one word with another (semantic paraphasias), and repeat words spoken by others (echolalia). Difficulties with speech and language worsen over time, and most affected individuals eventually lose the ability to communicate.

FTDP-17 is also characterised by problems with movement that worsen over time. Many affected individuals develop features of parkinsonism, including tremors, rigidity, and unusually slow movement (bradykinesia). As the disease progresses, most affected individuals become unable to walk. Some people with FTDP-17 also have restricted up-and-down eye movement (vertical gaze palsy) and rapid abnormal movements of both eyes (saccades).

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

DDPAC

Disinhibition-dementia-parkinsonism-amytrophy complex

Familial Pick's disease

FTDP-17

Wilhelmsen-Lynch disease

Patient picks for Genetic conditions

Related patient information and medicines

Memory loss and dementia

Patient information leaflet

Memory loss and dementia

Lewy body dementia This is a type of dementia caused by lumps of protein in... Frontotemporal dementia This is a type of dementia that causes the frontal and temporal lobes of the brain to shrink and stop working. Other types of dementia There are many other types of dementia, such as: Dementia due to Parkinson's disease Parkinson's disease. The.

Causes of memory loss and dementia

Patient information leaflet

Causes of memory loss and dementia

People with Down's syndrome are more likely to develop Alzheimer's disease. Parkinson's disease Parkinson's disease. As many as half of people with Parkinson's disease may develop dementia. If Lewy bodies develop in a part of the brain called the brain stem, as well as symptoms of dementia, someone may also develop symptoms similar to Parkinson's.

Parkinson's disease

Patient information leaflet

Parkinson's disease

Parkinson's disease is a progressive... The cells in the brain affected in PD are not in the 'thinking' parts of the brain and dementia is not a typical early feature of PD Memory loss and dementia. About half of people with Parkinson's disease develop dementia at some stage. If dementia occurs, it tends to develop in older people with PD (aged.

Temporal lobe lesions

Patient information leaflet

Temporal lobe lesions

A serious head injury Head injuries or a surgical operation to remove a brain tumour may may also cause damage or injury to the temporal lobe. Progressive worsening of language can be part of a type of dementia Memory loss and dementia called frontotemporal dementia. Frontotemporal dementia The temporal lobe can be affected by an infection of the.

Apathy

Patient information leaflet

Apathy

Apathy is also associated with various other conditions, including various types of dementia Memory loss and dementia , Parkinson's disease Parkinson's disease and multiple sclerosis Multiple sclerosis , and following a stroke Stroke. Diagnosing apathy The diagnosis of apathy is made by a health professional based on: Your medical and medication.

Medication and treatment for dementia

Patient information leaflet

Medication and treatment for dementia

However, doctors should never work outside of their skills and many GPs may stil... The medicine rivastigmine is also licensed to be used in people with mild-to-moderately severe dementia who also have Parkinson's disease Parkinson's disease. Also, an acetylcholinesterase inhibitor medicine may sometimes be suggested for people with dementia with.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 13 Nov 2023 | Latest version
  • 1 Mar 2011 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.